Who owns OLEMA PHARMACEUTICALS INC?
- Ticker: OLMA
- CUSIP Number: 68062p106
Tip: Access positions for across all investors
Analyze quarterly positions in Olema Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Olema Pharmaceuticals stock
Who bought or sold OLEMA PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 9.1M | $128M | 0% | Dec 2023 |
|
Paradigm Biocapital Advisors | 7.9M | $111M | 1% | Dec 2023 |
|
Logos Global Management | 4.4M | $54M | 17% | Dec 2023 |
|
Vanguard Group | 2.7M | $38M | 58% | Dec 2023 |
|
Cormorant Asset Management | 2.5M | $35M | -45% | Dec 2023 |
|
Vivo Capital | 1.9M | $21M | 0% | Mar 2024 |
|
Dimensional Fund Advisors | 1.7M | $24M | 1% | Dec 2023 |
|
Henderson Group | 700k | $9.8M | 100% | Dec 2023 |
|
First Light Asset Management | 631k | $8.9M | 100% | Dec 2023 |
|
Victory Capital Management | 622k | $8.7M | 880% | Dec 2023 |
|
Kingdon Capital Management | 550k | $7.7M | 78% | Dec 2023 |
|
Perceptive Advisors | 540k | $7.6M | 100% | Dec 2023 |
|
Citadel Advisors | 341k | $4.8M | -27% | Dec 2023 |
|
Goldman Sachs Group | 316k | $4.4M | 236% | Dec 2023 |
|
Marshall Wace | 291k | $4.1M | 235% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 249k | $3.5M | 1613% | Dec 2023 |
|
Candriam Luxembourg S.C.A. | 215k | $3.0M | 100% | Dec 2023 |
|
Two Sigma Advisers | 181k | $2.5M | -25% | Dec 2023 |
|
Two Sigma Investments | 166k | $2.3M | 26% | Dec 2023 |
|
Newtyn Management | 150k | $2.1M | 0% | Dec 2023 |
|
Jacobs Levy Equity Management | 150k | $2.1M | -39% | Dec 2023 |
|
Bank of New York Mellon | 101k | $1.4M | 10% | Dec 2023 |
|
Wellington Management Company | 99k | $1.4M | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 89k | $1.3M | 12% | Dec 2023 |
|
Millennium Management | 87k | $1.2M | -59% | Dec 2023 |
|
VR Adviser | 77k | $1.1M | 0% | Dec 2023 |
|
Swiss National Bank | 65k | $906k | 100% | Dec 2023 |
|
Hudson Bay Capital Management | 63k | $877k | 100% | Dec 2023 |
|
UBS Group | 53k | $737k | 275% | Dec 2023 |
|
J. Goldman & Co | 51k | $712k | 62% | Dec 2023 |
|
EP Wealth Advisors | 46k | $649k | 0% | Dec 2023 |
|
Squarepoint Ops | 46k | $642k | 100% | Dec 2023 |
|
GSA Capital Partners | 44k | $621k | -26% | Dec 2023 |
|
Credit Suisse | 44k | $612k | 100% | Dec 2023 |
|
Barclays | 43k | $609k | 832% | Dec 2023 |
|
Rhumbline Advisers | 40k | $564k | 6% | Dec 2023 |
|
Bank of America Corporation | 40k | $563k | 6% | Dec 2023 |
|
Fred Alger Management | 40k | $555k | 100% | Dec 2023 |
|
ALPS Advisors | 38k | $535k | 100% | Dec 2023 |
|
Jane Street | 36k | $507k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 29k | $401k | 56% | Dec 2023 |
|
Walleye Trading Advisors | 29k | $401k | -83% | Dec 2023 |
|
Caption Management | 27k | $379k | 100% | Dec 2023 |
|
State of Wisconsin Investment Board | 27k | $378k | 100% | Dec 2023 |
|
T. Rowe Price Associates | 25k | $348k | -36% | Dec 2023 |
|
Legal & General Group | 25k | $344k | 911% | Dec 2023 |
|
Ubs Global Asset Management Americas | 21k | $300k | 100% | Dec 2023 |
|
Jump Financial | 20k | $278k | 100% | Dec 2023 |
|
Simplex Trading | 19k | $261k | 100% | Dec 2023 |
|
Mirae Asset Global Investments | 16k | $224k | 9% | Dec 2023 |
|
SG Americas Securities | 16k | $223k | 38% | Dec 2023 |
|
Alliancebernstein | 16k | $223k | 46% | Dec 2023 |
|
MetLife Investment Advisors | 15k | $209k | 0% | Dec 2023 |
|
American International | 13k | $187k | 0% | Dec 2023 |
|
Franklin Resources | 13k | $181k | 0% | Dec 2023 |
|
D. E. Shaw & Co | 12k | $167k | 100% | Dec 2023 |
|
Walleye Trading | 12k | $161k | -50% | Dec 2023 |
|
AQR Capital Management | 11k | $151k | 7% | Dec 2023 |
|
Zurcher Kantonalbank | 9.3k | $130k | 100% | Dec 2023 |
|
Wells Fargo & Company | 8.5k | $119k | 26% | Dec 2023 |
|
Royal Bank of Canada | 8.1k | $113k | 81% | Dec 2023 |
|
Virtus ETF Advisers | 7.5k | $105k | 100% | Dec 2023 |
|
New York State Common Retirement Fund | 6.5k | $91k | -1% | Dec 2023 |
|
China Universal Asset Management | 6.3k | $89k | 100% | Dec 2023 |
|
Citigroup | 4.8k | $67k | 31947% | Dec 2023 |
|
Summit Investment Advisors | 2.2k | $31k | 0% | Dec 2023 |
|
Metropolitan Life Insurance Company | 1.5k | $22k | 0% | Dec 2023 |
|
CWM | 1.0k | $12k | 0% | Mar 2024 |
|
Amalgamated Bank | 906.00 | $10k | -61% | Mar 2024 |
|
Wolff Wiese Magana | 600.00 | $6.8k | 100% | Mar 2024 |
|
Fortitude Family Office | 319.00 | $3.6k | 0% | Mar 2024 |
|
Daiwa Securities Group | 224.00 | $3.0k | 100% | Dec 2023 |
|
Lindbrook Capital | 158.00 | $2.2k | 0% | Dec 2023 |
|
Us Bancorp | 143.00 | $2.0k | 100% | Dec 2023 |
|
NISA Investment Advisors | 40.00 | $561.000000 | 100% | Dec 2023 |
|
GAMMA Investing | 14.00 | $157.999800 | 100% | Mar 2024 |
|
Who sold out of Olema Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Kynam Capital Management | Sep 2023 | 235k | $2.9M |
Vontobel Holding | Sep 2023 | 164k | $2.0M |
Aquilo Capital Management | Sep 2023 | 89k | $1.1M |
Schonfeld Strategic Advisors | Sep 2023 | 72k | $894k |
Endurant Capital Management | Sep 2023 | 59k | $723k |
Algert Coldiron Investors | Sep 2023 | 48k | $588k |
Caxton Associates | Sep 2023 | 14k | $166k |
Trexquant Investment | Sep 2023 | 11k | $138k |
Ohio Pers | Sep 2023 | 2.9k | $35k |
Federated Investors | Sep 2023 | 1.0k | $13k |